Home › Funds › CM Management, LLC › LTRN
CM Management, LLC position in LTRN
LANTERN PHARMA INC · Health Care
CM Management, LLC reported holding 500,000 shares of LTRN (LANTERN PHARMA INC) in its Q2 2026 13F filing — a position valued at US$2.1M, representing 1.32% of its reported portfolio and ranking #32 among its reported holdings. CM Management, LLC has disclosed LTRN holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How CM Management, LLC's LTRN position evolved
CM Management, LLC first disclosed a stake in LTRN in Q3 2023 at 75,000 shares (US$256K). The position peaked in Q2 2026 at 500,000 shares, worth US$2.1M. Across 12 filings, CM Management, LLC increased the stake 7 time(s), trimmed it 1 time(s) and left it unchanged 3 time(s). The most recent filing (Q2 2026) shows 500,000 shares valued at US$2.1M — an increase of 250,000 shares quarter over quarter.. Notable position changes include a 131% increase in Q3 2024 (shares fell 13% over the following quarter), a 100% increase in Q2 2026 (shares fell 76% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 75.00K | $255.75K | New |
| Q4 2023 | 80.00K | $342.40K | Add |
| Q1 2024 | 65.00K | $572.00K | Reduce |
| Q2 2024 | 80.00K | $373.60K | Add |
| Q3 2024 | 185.00K | $678.95K | Add |
| Q4 2024 | 200.00K | $638.00K | Add |
| Q1 2025 | 200.00K | $708.00K | Hold |
| Q2 2025 | 200.00K | $632.00K | Hold |
| Q3 2025 | 225.00K | $978.75K | Add |
| Q4 2025 | 225.00K | $681.75K | Hold |
| Q1 2026 | 250.00K | $342.50K | Add |
| Q2 2026 | 500.00K | $2.08M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About LTRN and 13F data
LTRN (LANTERN PHARMA INC) is a Health Care company. 27 other funds we track also report a position in LTRN — the largest reported positions include Empery Asset Management, LP (US$3.5M), BIOS Capital Management, LP (US$1.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding LTRN
- Empery Asset Management, LP 842.67K sh · $3.51M · Q2 2026
- BIOS Capital Management, LP 249.40K sh · $1.04M · Q2 2026
More on CM Management, LLC
FAQ
How long has CM Management, LLC held LTRN?
CM Management, LLC has disclosed LTRN holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is CM Management, LLC's current position in LTRN?
As of Q2 2026, CM Management, LLC holds 500.00K shares of LTRN (LANTERN PHARMA INC), valued at $2.08M, representing 1.32% of its reported portfolio and ranking #32.
Has CM Management, LLC been buying or selling LTRN?
In the latest 13F filing (Q2 2026), CM Management, LLC increased its position in LTRN. The position peaked in Q2 2026 at 500.00K shares.
Which other funds hold LTRN?
Other major institutional holders of LTRN include Empery Asset Management, LP, BIOS Capital Management, LP, among 27 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.